Envista Holdings Corp

NYSE:NVST

Medical - Equipment & Services

Healthcare
$23.75 +3.06%

+$0.76 today

Market cap
$3.81B
Beta
0.89
P/E (TTM)
62.0
EPS (TTM)
$0.41
52W Low $18.32High $30.42

Volume 1.92M

Average 2.94M

NVST Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Envista Holdings CorpNYSE: NVST

Weighted Avg Shares · Q3 FY2026 · quarter ended Oct 2026

Weighted avg shares declines year over year

Q3 FY2026 weighted avg shares of 160.8M shares fell 5.0% year over year, in line with the -4.7% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.7% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -5.0% toward the trailing-twelve-month pace of -4.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterOct 2026
160.8M-0.7% QoQ
Last fiscal yearDec 2025
168M-2.4% YoY
LTMOct 2026
162.75M-4.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.0%——
1 year-2.4%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
168M USD
Year-over-year change
-2.4%
4-year CAGR
+1.0%

Weighted Avg Shares vs competitors

How NVST compares with its peers on the latest reported figures

  • NVST's LTM Oct 2026 weighted avg shares of 162.75M shares is the 3rd highest of the 11 companies compared; the peer median is 111.87M shares.
  • Its year-over-year change of -4.7% is the lowest of 11, against a peer median of +3.9%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +3.2%.
NVST Competitors Peer median
Weighted Avg Shares for NVST and competitors
Company Period LTM YoY 3-year CAGR
ALHCAlignment Healthcare, Inc.LTM Mar 2026200.92M +4.7%+3.0%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026199.58M -1.3%-2.6%
NVSTEnvista Holdings CorpLTM Oct 2026162.75M -4.7%+1.0%
DYNDyne Therapeutics, Inc.LTM Jun 2026150.19M +40.8%+35.2%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026126.76M -0.2%+0.0%
PRVAPrivia Health Group, Inc.LTM Jun 2026124.06M +2.8%+3.3%
RAREUltragenyx Pharmaceutical Inc.LTM Mar 202699.68M +6.6%+12.1%
APGEApogee Therapeutics, Inc.LTM Jun 202666.14M +15.7%+6.2%
SUPNSupernus Pharmaceuticals, Inc.LTM Jun 202657.36M +3.1%+1.7%
GRALGRAIL, Inc.LTM Jun 202640.15M +20.6%+5.8%
ICUIICU Medical, Inc.LTM Jun 202624.78M +1.0%+1.1%
Peer median (excluding NVST) 111.87M+3.9%+3.2%

Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.51B2.57B2.57B2.51B2.72B
Cost of Revenue1.05B1.08B1.12B1.12B1.22B
Gross Profit1.46B1.49B1.45B1.39B1.5B
Gross Margin58.3%57.9%56.5%55.4%55.0%
Research & Development100.5M100.1M93.8M99.1M114M
Selling, General & Admin989.5M1.03B1.03B1.14B1.16B
Operating Expenses1.16B1.17B1.42B2.43B1.27B
Depreciation & Amortization151.9M162.1M162.6M123.1M116M
EBITDA524.3M522M490M279.5M329.8M
EBITDA Margin20.9%20.3%19.1%11.1%12.1%
Operating Income306.2M319.2M31.5M(1.04B)225.7M
Operating Margin12.2%12.4%1.2%-41.4%8.3%
Interest Income00000
Interest Expense54.1M38.4M63.4M46.4M36.6M
Other Income / Expenses(51.7M)(35.3M)(86.4M)(46.5M)(48.5M)
Income Before Tax254.5M283.9M(54.9M)(1.08B)177.2M
Pre-Tax Margin10.1%11.1%-2.1%-43.2%6.5%
Income Tax Expense(9M)45.9M45.3M33.9M130.2M
Net Income340.5M243.1M(100.2M)(1.12B)47M
Net Margin13.6%9.5%-3.9%-44.6%1.7%
EPS (Basic)1.631.46(0.60)(6.50)0.28
EPS (Diluted)1.481.34(0.60)(6.50)0.28
Weighted Avg Shares161.2M162.9M166.9M172.2M168M
Weighted Avg Shares (Diluted)177.6M177.6M166.9M172.2M169.2M

Envista Holdings Corp

NYSE:NVST

Intrinsic Alpha fair value

Locked

Current Price

$23.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.